Parse Biosciences Analysis: $9M Raised
What is Parse Biosciences?
Scalable single cell sequencing technology
Location
Seattle, United States
Employees
51-200
Founded
2018
Product Features & Capabilities
- Evercode WT Mini
- Evercode WT
- Evercode WT Mega
- Evercode WT Penta
- Evercode TCR
- Evercode BCR
- Evercode Fixation
- Gene Select
- CRISPR Detect
Use Cases
Conduct single cell experiments with up to 5 million cells; Profile immune repertoires using Evercode TCR and BCR; Perform time-course experiments with sample fixation; Analyze single cell data using Trailmaker software; Scale experiments to 384 samples in a single run
Other Considerations
Acquired by QIAGEN in 2025; Serves over 3,000 laboratories globally; Recognized for high data quality in single cell sequencing; Partnerships with various research institutions
See something that needs updating? Suggest edits to this profile.